Association of Biotechnology Led Enterprises

News

Affinity discovers potent SARS-CoV-2 antibodies

After discovering a number of candidate antibodies that block the virus spike protein from binding to its human receptor, Affinity engaged Doherty Institute to conduct testing using the virus in the laboratory.

Jul 02, 2020

By : Team ABLE

Dr Reddy’s Labs, ABLE member, to make Favipiravir with Fujifilm Toyoma tie-up for India, global markets treat COVID-19

A Tripartite Licensing Agreement was concluded between Fujifilm Toyama, Dr. Reddy's Laboratories and GRA, concerning the development, manufacture and sales of Favipiravir ( Avigan) tablets used to treat COVID-19 patients

Jul 02, 2020

By : Team ABLE

Hetero starts supply of Covifor, its Remdesivir generic drug for COVID-19 treatment

ABLE member company, Hetero Drugs, through its subsidiary Hetero Healthcare Ltd, has started supply initial batch of 20,000 vials of Covifor, the Remdesivir generic version made under license from American company, Gilead Sciences

Jul 01, 2020

By : Team ABLE

NBRI establishes advanced virology lab for COVID-19 testing at Lucknow

It is a Bio Safety Level (BSL) 3 level facility and has been developed based on the guidelines of the Indian Council Medical Research (ICMR), the World Health Organisation (WHO), and the Ministry of Health and Family Welfare.

Jul 01, 2020

By : Team ABLE

ABLE member Bharat Biotech gets regulatory nod for India’s first COVID-19 vaccine human trials

Covaxin is the first home made vaccine to reach this stage of clinical trials in humans. The vaccine has been developed in collaboration with ICMR-National Institute fo Virology, Pune.

Jun 30, 2020

By : Team ABLE